Search research articles
Contact Us
Filters
Showing results (81-90 of 190) with videos related to
Page
of 19
Sort By:
Clinical Lung Cancer
|
March 6, 2012
Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption
Kevin Hollevoet, Marijn M Speeckaert, An-Sofie Decavele, et al.
Journal of Breath Research
|
June 30, 2020
The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?
Kevin Lamote, Eline Janssens, Eline Schillebeeckx, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Real-life treatment practice for malignant pleural mesothelioma in Belgium
Michael Rosskamp, Gilles Macq, Kristiaan Nackaerts, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2018
Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium
Michael Rosskamp, Harlinde De Schutter, Kris Henau, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 14, 2026
Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells
Eline Janssens, Ellen Heirwegh, An Wouters, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 8, 2017
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
Youssef Ben Bouazza, Ibrahim Chiairi, Ouiam El Kharbouchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 5, 2008
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
Kurt G Tournoy, Frédéric De Ryck, Lieve Vanwalleghem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis
Janah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody
Jo Raskin, Pegah Masrori, Antonin Cant, et al.
Expert Opinion on Investigational Drugs
|
June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
Christian Rolfo, Luis E Raez, Giuseppe Bronte, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 190) with videos related to
Sort By:
Page
of 19
Clinical Lung Cancer
|
March 6, 2012
Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption
Kevin Hollevoet, Marijn M Speeckaert, An-Sofie Decavele, et al.
Journal of Breath Research
|
June 30, 2020
The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?
Kevin Lamote, Eline Janssens, Eline Schillebeeckx, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2018
Real-life treatment practice for malignant pleural mesothelioma in Belgium
Michael Rosskamp, Gilles Macq, Kristiaan Nackaerts, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2018
Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium
Michael Rosskamp, Harlinde De Schutter, Kris Henau, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 14, 2026
Hypoxia induces alterations in the volatile signature of pleural mesothelioma cells
Eline Janssens, Ellen Heirwegh, An Wouters, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 8, 2017
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
Youssef Ben Bouazza, Ibrahim Chiairi, Ouiam El Kharbouchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 5, 2008
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
Kurt G Tournoy, Frédéric De Ryck, Lieve Vanwalleghem, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-Analysis
Janah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody
Jo Raskin, Pegah Masrori, Antonin Cant, et al.
Expert Opinion on Investigational Drugs
|
June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
Christian Rolfo, Luis E Raez, Giuseppe Bronte, et al.
Page
of 19